113 related articles for article (PubMed ID: 8929382)
1. Clinical evaluation of gadodiamide injection in paediatric MR imaging.
Hanquinet S; Christophe C; Greef DD; Gordon P; Perlmutter N
Pediatr Radiol; 1996 Nov; 26(11):806-10. PubMed ID: 8929382
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the safety of standard and triple dose gadodiamide injection in MR imaging of the central nervous system. A double-blind study.
Svaland MG; Christensen T; Lundorf E
Acta Radiol; 1994 Jul; 35(4):396-9. PubMed ID: 8011392
[TBL] [Abstract][Full Text] [Related]
3. Brain metastases--comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhanced MR imaging.
Akeson P; Larsson EM; Kristoffersen DT; Jonsson E; Holtås S
Acta Radiol; 1995 May; 36(3):300-6. PubMed ID: 7742127
[TBL] [Abstract][Full Text] [Related]
4. MR imaging of pituitary region lesions with gadodiamide injection.
Hald JK; Skalpe IO; Bakke SJ; Nakstad PH
Acta Radiol; 1994 Jan; 35(1):65-9. PubMed ID: 8305277
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the clinical safety of gadodiamide injection, a new nonionic MRI contrast medium for the central nervous system: a European perspective.
Aslanian V; Lemaignen H; Bunouf P; Svaland MG; Borseth A; Lundby B
Neuroradiology; 1996 Aug; 38(6):537-41. PubMed ID: 8880714
[TBL] [Abstract][Full Text] [Related]
6. MRI in children given gadodiamide injection: safety and efficacy in CNS and body indications.
Lundby B; Gordon P; Hugo F
Eur J Radiol; 1996 Nov; 23(3):190-6. PubMed ID: 9003923
[TBL] [Abstract][Full Text] [Related]
7. [Use of Omniscan (gadodiamide) in magnetic resonance studies of the central nervous system (results of a multicenter study)].
Sinitsyn VE; Kornienko VN; Nikitin VG; Pronin IN; Ternovoĭ SK; Tiutin LA; Iakobson MG
Vestn Rentgenol Radiol; 1995; (4):5-11. PubMed ID: 8571538
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the safety of the standard dose and a higher dose of gadodiamide injection for MR imaging of the central nervous system.
Svaland MG; Lundby B; Kristoffersen DT
J Magn Reson Imaging; 1994; 4(3):419-23. PubMed ID: 8061442
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of the tolerability of gadodiamide, a new nonionic contrast agent in MRI of the central nervous system].
Aslanian V; Lemaignen H; Bunouf P; Schiratti M; Lambrechts M; Lundby B; Borseth A; Svaland M
J Radiol; 1995 Jul; 76(7):431-4. PubMed ID: 7473377
[TBL] [Abstract][Full Text] [Related]
10. Gadodiamide injection at 0.1 and 0.3 mmol/kg body weight: a phase III double-blind, parallel, randomised clinical investigation of known or suspected central nervous system lesions at 1.5 T.
Demaerel P; Marchal G; Wilms G; Van Calenbergh F; De Greef D; Børseth A; Baert AL
Neuroradiology; 1994 Jul; 36(5):355-9. PubMed ID: 7936174
[TBL] [Abstract][Full Text] [Related]
11. Acute hemodynamic effects of nonionic and ionic magnetic resonance contrast media in intravenous bolus injection in rats.
Masui T; Takehara Y; Aoshima R; Kaneko M
Invest Radiol; 1994 Jun; 29 Suppl 2():S189-91. PubMed ID: 7928226
[No Abstract] [Full Text] [Related]
12. Safety of gadodiamide injection in two different age groups.
Högström B; Kristoffersen DT; Lundby B; Svaland MG
J Magn Reson Imaging; 1996; 6(1):255-7. PubMed ID: 8851438
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, comparative study of gadodiamide injection and gadopentetate dimeglumine in MRI of the central nervous system.
Valk J; Algra PR; Hazenberg CJ; Slooff WB; Svaland MG
Neuroradiology; 1993; 35(3):173-7. PubMed ID: 8459913
[TBL] [Abstract][Full Text] [Related]
14. Tolerance and efficacy of Omniscan (gadodiamide injection) in MR imaging of the central nervous system.
Ekholm S; Jonsson E; Sandvik L; Fagerlund M; Holtås S; Isberg B; Lindell D; Lindén B; Sjöberg S; Thuomas KA; Tollesson PO
Acta Radiol; 1996 Mar; 37(2):223-8. PubMed ID: 8600967
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced MRI of the central nervous system: comparison between gadodiamide injection and gadolinium-DTPA.
Akeson P; Jonsson E; Haugen I; Holtås S
Neuroradiology; 1995 Apr; 37(3):229-33. PubMed ID: 7603600
[TBL] [Abstract][Full Text] [Related]
16. Brain lesion contrast in MR imaging. Dependence on field strength and concentration of gadodiamide injection in patients and phantoms.
Akeson P; Vikhoff B; Ståhlberg F; Holtås S
Acta Radiol; 1997 Jan; 38(1):14-8. PubMed ID: 9059395
[TBL] [Abstract][Full Text] [Related]
17. Interference of gadodiamide injection (OMNISCAN) on the colorimetric determination of serum calcium.
Normann PT; Frøysa A; Svaland M
Scand J Clin Lab Invest; 1995 Aug; 55(5):421-6. PubMed ID: 8545600
[TBL] [Abstract][Full Text] [Related]
18. Use of the magnetic resonance contrast agent gadodiamide in the central nervous system. Results of a multicenter trial.
Sze G; Brant-Zawadzki M; McNamara MT; Haughton VM; Kumar AJ; Maravilla KR; Aisen AM; Dreisbach JN; Bradley WG; Weinreb JC
Invest Radiol; 1993 Mar; 28 Suppl 1():S49-55. PubMed ID: 8486504
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced MRI with gadodiamide injection in rat disease models.
Yamada K; Miyahara K; Sato H; Nakayama W; Sato M; Hirose T; Kato H; Ikehira H; Tateno Y; Sugihara H; Furuhama K
J Vet Med Sci; 1996 Apr; 58(4):291-5. PubMed ID: 8741259
[TBL] [Abstract][Full Text] [Related]
20. [Gadodiamide and gadolinium-DTPA as intravenous media in computed tomography].
Engelbrecht V; Koch JA; Rassek M; Mödder U
Rofo; 1996 Jul; 165(1):24-8. PubMed ID: 8765359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
